🔎 Trials Near Me

Akèy › Hyperlipoprotéinémie de type II › Utah › Salt Lake City

Etid klinik pou Hyperlipoprotéinémie de type II nan Salt Lake City, UT

3 etid pou Hyperlipoprotéinémie de type II ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

Ap rekriteFaz 3
  • Primary Childrens Medical Center, Salt Lake City
Laj 2 a 100 · Tout sèks · Mizajou Sep 18, 2026 · NCT05682378

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • Primary Childrens Medical Center, Salt Lake City
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • Primary Childrens Medical Center, Salt Lake City
  • Primary Childrens Medical Center, Salt Lake City
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.